Last reviewed · How we verify
Tetanus toxoid adsorbed booster vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Tetanus toxoid adsorbed booster vaccine (Tetanus toxoid adsorbed booster vaccine) — Genentech, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tetanus toxoid adsorbed booster vaccine TARGET | Tetanus toxoid adsorbed booster vaccine | Genentech, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tetanus toxoid adsorbed booster vaccine CI watch — RSS
- Tetanus toxoid adsorbed booster vaccine CI watch — Atom
- Tetanus toxoid adsorbed booster vaccine CI watch — JSON
- Tetanus toxoid adsorbed booster vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Tetanus toxoid adsorbed booster vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/tetanus-toxoid-adsorbed-booster-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab